AAAAAA
Results:
1-21
|
Results: 21
Authors:
LOEBSTEIN R
LEHOTAY D
SHER G
Citation: R. Loebstein et al., THE ROLE OF IRON-DERIVED FREE-RADICALS IN THE DEVELOPMENT OF DIABETICNEPHROPATHY IN PATIENTS WITH BETA-THALASSEMIA, The FASEB journal, 12(5), 1998, pp. 4417-4417
Authors:
LOEBSTEIN R
LEHOTAY DC
LUO XP
BARTFAY W
TYLER B
SHER GD
Citation: R. Loebstein et al., DIABETIC NEPHROPATHY IN HYPERTRANSFUSED PATIENTS WITH BETA-THALASSEMIA - THE ROLE OF OXIDATIVE STRESS, Diabetes care, 21(8), 1998, pp. 1306-1309
Authors:
LOEBSTEIN R
ADDIS A
HO E
ANDREOU R
SAGE S
DONNENFELD AE
SCHICK B
BONATI M
MORETTI M
LALKIN A
PASTUSZAK A
KOREN GI
Citation: R. Loebstein et al., PREGNANCY OUTCOME FOLLOWING GESTATIONAL EXPOSURE TO FLUOROQUINOLONES - A MULTICENTER PROSPECTIVE CONTROLLED-STUDY, Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1336-1339
Authors:
LOEBSTEIN R
KOREN G
Citation: R. Loebstein et G. Koren, IFOSFAMIDE-INDUCED NEPHROTOXICITY IN CHILDREN - CRITICAL-REVIEW OF PREDICTIVE RISK-FACTORS, Pediatrics, 101(6), 1998, pp. 81-84
Authors:
LOEBSTEIN R
ADDIS A
HO E
DONNENFELD A
KOREN G
Citation: R. Loebstein et al., PREGNANCY OUTCOME FOLLOWING EXPOSURE TO FLUOROQUINOLONES (FQ) - MISPERCEPTION OF THE TERATOGENIC RISK, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 30-30
Authors:
ADDIS A
LOEBSTEIN R
KOREN G
EINARSON TR
Citation: A. Addis et al., METAANALYSIS OF THE CLINICAL EFFECTIVENESS OF ORAL DEFERIPRONE (L1), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 68-68
Authors:
LALKIN A
LOEBSTEIN R
ADDIS A
KOREN G
Citation: A. Lalkin et al., SAFETY OF OMEPRAZOLE DURING PREGNANCY - A MULTICENTER PROSPECTIVE COHORT STUDY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 69-69
Authors:
KOREN G
LOEBSTEIN R
NULMAN I
Citation: G. Koren et al., FETAL ALCOHOL SYNDROME - ROLE OF THE FAMILY PHYSICIAN, Canadian family physician, 44, 1998, pp. 38-40
Authors:
INOCENCION G
LOEBSTEIN R
LALKIN A
GEIST R
PETRIC M
KOREN G
Citation: G. Inocencion et al., MANAGING EXPOSURE TO CHICKENPOX DURING PREGNANCY - NEW PROGRAM, Canadian family physician, 44, 1998, pp. 745-746
Authors:
LALKIN A
LOEBSTEIN R
ADDIS A
RAMEZANINAMIN F
MASTROIACOVO P
MAZZONE T
VIAL T
BONATI M
KOREN G
Citation: A. Lalkin et al., THE SAFETY OF OMEPRAZOLE DURING PREGNANCY - A MULTICENTER PROSPECTIVECONTROLLED-STUDY, American journal of obstetrics and gynecology, 179(3), 1998, pp. 727-730
Authors:
LOEBSTEIN R
KOREN G
Citation: R. Loebstein et G. Koren, PREGNANCY OUTCOME AND NEURODEVELOPMENT OF CHILDREN EXPOSED IN-UTERO TO PSYCHOACTIVE-DRUGS - THE MOTHERISK EXPERIENCE, Journal of psychiatry & neuroscience, 22(3), 1997, pp. 192-196
Authors:
LOEBSTEIN R
DIAVCITRIN O
ATANACKOVIC G
OLIVIERI NF
KOREN G
Citation: R. Loebstein et al., DEFERIPRONE-INDUCED AGRANULOCYTOSIS - A CRITICAL-REVIEW OF 5 RECHALLENGED CASES, Clinical drug investigation, 13(6), 1997, pp. 345-349
Authors:
LOEBSTEIN R
LALKIN A
KOREN G
Citation: R. Loebstein et al., PHARMACOKINETIC CHANGES DURING PREGNANCY AND THEIR CLINICAL RELEVANCE, Clinical pharmacokinetics, 33(5), 1997, pp. 328-343
Authors:
LOEBSTEIN R
KOREN G
Citation: R. Loebstein et G. Koren, THE ETHICS OF MULTIPLE BLOOD-SAMPLING IN CHILDREN FOR RESEARCH, Therapeutic drug monitoring, 19(3), 1997, pp. 251-251
Authors:
BAILEY B
LOEBSTEIN R
LAI C
MCGUIGAN MA
Citation: B. Bailey et al., 2 CASES OF CHLORINATED HYDROCARBON-ASSOCIATED MYOCARDIAL-ISCHEMIA, Veterinary and human toxicology, 39(5), 1997, pp. 298-301
Authors:
LOEBSTEIN R
ZAHID N
DIAVCITRIN O
ATANACKOVIC G
UETRECHT J
KOREN G
Citation: R. Loebstein et al., DEFERIPRONE(L1)-INDUCED AGRANULOCYTOSIS - A POSSIBLE MECHANISM, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 9-9
Authors:
DIAVCITRIN O
ATANACKOVIC G
LOEBSTEIN R
KOREN G
Citation: O. Diavcitrin et al., INVESTIGATION OF VARIABILITY IN RESPONSE TO DEFERIPRONE(L1) IN PATIENTS WITH BETA-THALASSEMIA MAJOR, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 38-38
Authors:
LALKIN A
MAGEE L
ADDIS A
LOEBSTEIN R
KOREN G
Citation: A. Lalkin et al., ACID-SUPPRESSING DRUGS DURING PREGNANCY, Canadian family physician, 43, 1997, pp. 1923-1924
Authors:
LOEBSTEIN R
DALAL I
NISBETBROWN E
BERKOVITCH M
MEYDAN N
ANDREWS D
LOUBSER MD
KOREN G
ROIFMAN CM
OLIVIERI NF
Citation: R. Loebstein et al., IMMUNE FUNCTION IN PATIENTS WITH BETA-THALASSEMIA RECEIVING THE ORALLY-ACTIVE IRON-CHELATING AGENT DEFERIPRONE, British Journal of Haematology, 98(3), 1997, pp. 597-600
Authors:
ADDIS A
LOEBSTEIN R
KOREA G
EINARSON TR
FREEDMAN M
Citation: A. Addis et al., METAANALYSIS OF THE CLINICAL EFFECTIVENESS OF ORAL DEFERIPRONE (L1), Blood, 90(10), 1997, pp. 2722-2722
Authors:
LOEBSTEIN R
TYLER B
KWAN J
OLIVIERI NF
SHER GD
Citation: R. Loebstein et al., RISK-FACTORS FOR AND PATHOGENESIS OF DIABETES-MELLITUS IN HYPERTRANSFUSED PATIENTS WITH HOMOZYGOUS BETA-THALASSEMIA (HBT), Blood, 88(10), 1996, pp. 2828-2828
Risultati:
1-21
|